Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRO
8626
PUT
DELISTED
PROS Holdings
PRO
| $485K | ﹤0.01% |
+18,500
| New | +$523K |
|
8627
CALL
Smart Sand
SND
$208M
| $485K | ﹤0.01% |
242,300
+29,700
| +14% | +$103K |
|
8628
PUT
Diodes
DIOD
$4.95B
| $484K | ﹤0.01% |
7,500
-4,900
| -40% | -$357K |
|
8629
CALL
Keros Therapeutics
KROS
$208M
| $484K | ﹤0.01% |
17,500
+10,400
| +146% | +$456K |
|
8630
PUT
Navient
NAVI
$859M
| $484K | ﹤0.01% |
34,600
+4,100
| +13% | +$63.8K |
|
8631
Relay Therapeutics
RLAY
$4.53B
| $484K | ﹤0.01% |
28,919
-71,175
| -71% | -$1.53M |
|
8632
Vanguard Morningstar Mid-Cap ETF
VO
$111B
| $484K | ﹤0.01% |
9,836
-19,772
| -67% | -$1.07M |
|
8633
PUT
Colliers International
CIGI
$5.29B
| $483K | ﹤0.01% |
4,400
-10,500
| -70% | -$1.2M |
|
8634
PUT
CubeSmart
CUBE
$9.26B
| $483K | ﹤0.01% |
11,300
-1,800
| -14% | -$82.8K |
|
8635
Quanex
NX
$953M
| $483K | ﹤0.01% |
21,214
-2,744
| -11% | -$57.3K |
|
8636
Invesco Active US Real Estate Fund
PSR
$59.6M
| $483K | ﹤0.01% |
+5,054
| New | +$525K |
|
8637
CALL
First American
FAF
$7.47B
| $482K | ﹤0.01% |
9,100
-2,600
| -22% | -$151K |
|
8638
Invesco BulletShares 2028 Municipal Bond ETF
BSMS
$316M
| $481K | ﹤0.01% |
20,695
-43,960
| -68% | -$1.03M |
|
|
POWR
8639
iShares U.S. Power Infrastructure ETF
POWR
$468M
| $481K | ﹤0.01% |
+22,674
| New | +$532K |
|
8640
Fidelity Real Estate Investment ETF
FPRO
$16.5M
| $481K | ﹤0.01% |
+21,882
| New | +$524K |
|
8641
Direxion Daily MSCI Brazil Bull 2X ETF
BRZU
$89.9M
| $480K | ﹤0.01% |
7,449
+4,883
| +190% | +$446K |
|
8642
iShares Currency Hedged MSCI Japan ETF
HEWJ
$767M
| $480K | ﹤0.01% |
12,833
-82,116
| -86% | -$3.11M |
|
8643
CALL
Strategic Education
STRA
$1.79B
| $480K | ﹤0.01% |
6,800
-1,000
| -13% | -$66.3K |
|
8644
PUT
Twist Bioscience
TWST
$7.8B
| $479K | ﹤0.01% |
13,700
-10,000
| -42% | -$354K |
|
8645
PUT
Holley
HLLY
$370M
| $478K | ﹤0.01% |
45,500
+29,800
| +190% | +$325K |
|
|
ITI
8646
DELISTED
Iteris, Inc.
ITI
| $478K | ﹤0.01% |
165,087
+95,013
| +136% | +$264K |
|
|
SOVO
8647
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $478K | ﹤0.01% |
30,100
-139,299
| -82% | -$2.02M |
|
|
ASPY
8648
DELISTED
ASYMmetric Smart S&P 500 ETF
ASPY
| $478K | ﹤0.01% |
17,674
-7,539
| -30% | -$206K |
|
|
FOLD
8649
CALL
DELISTED
Amicus Therapeutics
FOLD
| $477K | ﹤0.01% |
44,400
+14,000
| +46% | +$115K |
|
8650
PUT
Gerdau
GGB
$9.42B
| $477K | ﹤0.01% |
140,238
+2,394
| +2% | +$10.7K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.